BioHybrid Solutions
Antonina Simakova is currently the Executive Vice President of Research at BioHybrid Solutions. With a Ph.D. in Chemistry from Carnegie Mellon University, Antonina has extensive experience in research and development, specializing in polymerization, bioconjugates, nanogels, and drug delivery systems. Prior to their current role, Antonina has held positions at Bayer MaterialScience, Ivanovsky Institute of Virology, and has completed various internships focusing on chemistry and catalysis. Their academic background includes a Bachelor's and Master's degree in Chemical Technology and Biotechnology.
BioHybrid Solutions
BioHybrid Solutions LLC (BHS) is a Carnegie Mellon University spin-off, focused on next-generation protein-polymer biotherapeutics as alternatives to PEGylation. A fast-growing company with a network of committed partners and collaborators working to deliver the next generation of biotherapeutics.